PUBLIC CONTRACT · 2022
050102302022 - Mepolizumab 100 mg/1 ml sol inj caneta 1 ml sc
- Contract value
- €275,535.00
- Signed on
- 27 June 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9341105PUBLISHED SUBJECT
050102302022 - MEPOLIZUMAB 100 MG/1 ML SOL INJ CANETA 1 ML SC
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Coimbra, Coimbra
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GlaxoSmithKline - Produtos Farmacêuticos Lda. · Tax ID 500139962
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €275,535.00
- Procedure base price
- €0.00
- Total effective price
- €275,535.00
- Publication date
- 7 July 2022
- Award date
- 27 June 2022
- Signing date
- 27 June 2022
- Performance period
- 187 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/12 - Medicamentos do aparelho respiratório
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5977326
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.